Efficacy and safety of poziotinib in treatment-naive HER2 exon 20 insertion (ex20ins) mutated non-small cell lung cancer (NSCLC): ZENITH20-4 Meeting Abstract

International Collaboration

cited authors

  • Sun, S.; Prelaj, A.; Baik, C.; Le, X.; Garassino, M.; Wollner, M.; Haura, E.; Piotrowska, Z.; Socinski, M.; Dreiling, L.; Bhat, G.; Lebel, F.; Cornelissen, R.

authors

Publication Date

  • March 1, 2022

webpage

published in

category

start page

  • S13

end page

  • S13

volume

  • 33